In neuroinflammatory diseases such as multiple sclerosis, ion channels may fan the embers of neurodegeneration. A new study shows that the cation channel TRPM4 (transient receptor potential melastatin 4) crucially contributes to axonal loss in an animal model of multiple sclerosis (pages 1805–1811).
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Trapp, B.D. & Nave, K.-A. Annu. Rev. Neurosci. 31, 247–269 (2008).
Stys, P.K., Zamponi, G.W., van Minnen, J. & Geurts, J.J.G. Nat. Rev. Neurosci. 13, 507–514 (2012).
Schattling, B. et al. Nat. Med. 18, 1805–1811 (2012).
Guinamard, R., Demion, M. & Launay, P. Physiology (Bethesda) 25, 155–164 (2010).
Trapp, B.D. & Stys, P.K. Lancet Neurol. 8, 280–291 (2009).
Kapoor, R. et al. Lancet Neurol. 9, 681–688 (2010).
Hayton, T. et al. J. Neurol. 259, 505–514 (2012).
Killestein, J., Rudick, R.A. & Polman, C.H. Lancet Neurol. 10, 1026–1034 (2011).
Lassmann, H., van Horssen, J. & Mahad, D. Nat. Rev. Neurol. 8, 647–656 (2012).
Friese, M.A. et al. Nat. Med. 13, 1483–1489 (2007).
Gadjanski, I. et al. Ann. Neurol. 66, 81–93 (2009).
Bittner, S. et al. Brain 132, 2501–2516 (2009).
Nikic´, I. et al. Nat. Med. 17, 495–499 (2011).
Ouardouz, M. et al. Ann. Neurol. 65, 160–166 (2009).
Franklin, R.J., Ffrench-Constant, C., Edgar, J.M. & Smith, K.J. Nat. Rev. Neurol. 8, 624–634 (2012).
Acknowledgements
I thank K. Ogston for editorial suggestions.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
R.H. has received personal compensation for activities such as advisory board service and/or consultancy fees from Teva, Sanofi-Aventis/Genzyme, Bayer, Merck-Serono, Biogen-Idec, Novartis and Morphosys, and has received research grant support from Teva, Bayer, Serono, Biogen-Idec and Novartis.
Rights and permissions
About this article
Cite this article
Hohlfeld, R. Ion channels boost axonal injury in multiple sclerosis. Nat Med 18, 1743–1745 (2012). https://doi.org/10.1038/nm.3021
Published:
Issue Date:
DOI: https://doi.org/10.1038/nm.3021
